A recent meta-analysis studying GLP-1 receptor agonist and arrhythmogenicity in T2DM patients revealed that there was no significant association between the risk of major arrhythmias and GLP-1 receptor agonist treatment [262]. Here, GLP1R is linked to type 2 diabetes mellitus.